Skip to main content
. 2019 Apr 12;9:5979. doi: 10.1038/s41598-019-42518-x

Table 2.

Correlation of clinical and laboratory variables with arylesterase activity in heart failure patients

Variables correlated to serum arylesterase activity Non-diabetic patients with HF Diabetic patients with HF
Correlation coefficient P-value Correlation coefficient P-value
Unadjusted Age −0.371 <0.001 −0.216 0.056
Log HbA1c 0.035 0.699 0.068 0.554
Total cholesterol 0.171 0.055 0.212 0.068
HDL cholesterol 0.270 0.002 0.111 0.344
ApoA-I 0.257 0.004 0.255 0.028
eGFR 0.142 0.100 0.190 0.096
Log NT-proBNP −0.257 0.004 −0.353 0.003
Log LVEF 0.098 0.254 0.303 0.007
NYHA class −0.301 <0.001 −0.474 <0.001
Adjusted* Log NT-proBNP −0.227 0.035 −0.313 0.025
Log LVEF 0.089 0.415 0.325 0.020
NYHA class −0.451 <0.001 −0.554 <0.001

HF, heart failure; HbA1c, glycated hemoglobin A1c; eGFR, estimated glomerular filtration rate; hsCRP, high-sentivity C-reactive protein; NT-proBNP, N-terminal pro-B-type natriuretic peptide; LVEF, left ventricular ejection fraction.

*After adjustment for ages, sex, log transformed hsCRP, eGFR, apo A-I, history of smoking, hypertension and myocardial infarction.